Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration. - Wang, Y.; Parlevliet, E. T.; Geerling, J. J.; van der Tuin, S. J. L.; Zhang, H.; Bieghs, V.; Jawad, A. H. M.; Shiri-Sverdlov, R.; Bot, I.; de Jager, S. C. A.; Havekes, L. M.; Romijn, J. A.; et al. (British Journal of Pharmacology, 2014)